Polyclonal Rabbit anti‑Human CELA3A / ELA3 Antibody (Biotin, aa16‑270, WB) LS‑C688263
Polyclonal Rabbit anti‑Human CELA3A / ELA3 Antibody (Biotin, aa16‑270, WB) LS‑C688263
Antibody:
CELA3A / ELA3 Rabbit anti-Human Polyclonal (aa16-270) (Biotin) Antibody
Reactivity:
Human, Mouse, Bovine
Format:
Biotin, Unmodified
Overview
Antibody:
CELA3A / ELA3 Rabbit anti-Human Polyclonal (aa16-270) (Biotin) Antibody
Reactivity:
Human, Mouse, Bovine
Format:
Biotin, Unmodified
Specifications
Description
ELA3 antibody LS-C688263 is a biotin-conjugated rabbit polyclonal antibody to ELA3 (CELA3A) (aa16-270) from human. It is reactive with human, mouse and bovine. Validated for WB.
Target
Human CELA3A / ELA3
Synonyms
CELA3A | ELA3 | Elastase 1 | Elastase-3A | Elastase 3A, pancreatic | Protease E | ELA3A | Elastase IIIA
Reactivity
Human, Mouse, Bovine
(tested or 100% immunogen sequence identity)
Conjugations
Biotin.
Also available
Unconjugated or conjugated with
FITC,
Cy3,
HRP,
APC,
PE,
APC, Cy7.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant ELA3A (Ser16-His270)
Specificity
The antibody is a rabbit polyclonal antibody raised against ELA3A.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, ELISA
Species:
Human
Applications:
ELISA
Reactivity:
Human
Range:
31.2-2000 pg/ml
Source:
E. coli
Tag:
His-GST, N-terminus
Source:
Human
Tag:
6His, C-terminus
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 1/15/2025